Thomas R Fuerst

15PUBLICATIONS
32CO-AUTHORS
Molecular targetsMedical devicesHaematological tumoursAgricultural molecular engineering of nucleic acids and proteinsBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 24, 2026
Engineered subtilisin protease degrades active KRAS in cancer cells leading to differential cell targeting.

|Aug 20, 2026
Incorporation of native HCV E1E2 into a nanoparticle vaccine platform.

|Feb 11, 2026
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

Linling He, Yi-Zong Lee, Yi-Nan Zhang

|Dec 22, 2025
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.

Yimeng Wang, Andrey Galkin, Xiaoran Shang

|Oct 28, 2025
Polyphosphazene-Mediated Assembly of TLR4 and TLR7/8 Agonists Enables a Potent Nano-Adjuvant Delivery System for Hepatitis C Virus Vaccine Antigens.

Alexander K Andrianov, Alexander Marin, Sarah Jeong

|Jan 24, 2025
Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist-Synthesis, Characterization, and In Vivo Activity.

Thomas R Fuerst, Alexander Marin, Sarah Jeong

Pageof 3

Frequent Collaborators

10 joint publications

Eric A Toth

8 joint publications

Alexander K Andrianov

4 joint publications

Benjamin M Janus

3 joint publications

Gilad Ofek